Take part in a paid clinical trial

At Nucleus Network, we take the time to understand you and your health history, so we can match you with clinical trials that truly fit.

Search trials
Expression of Interest

Current clinical trials

Filters Looking to join a trial? Use the filters to find your fit and check your eligibility.

The Elevate Study

MSP | Recruiting Soon

  • 612-315-6490

  • 8 nights

  • 1 clinic visit

  • 612-315-6490

At Nucleus Network, we lead the way in advancing medical research through clinical trials that explore new investigational medicines aimed at improving lives across a wide range of health conditions.
We’re currently inviting overweight or obese volunteers to take part in a clinical study long term weight management.

Requirements

  • Male or Female
  • Healthy or Patient
  • 18 - 70 years old
  • BMI 25.0 - 45 kg/m2
  • Non-smoker or Occasional smoker

Study visits

8 nights, 1 clinic visit

Remuneration

$8,000
Learn more about the Elevate Study

The Indigo Study

BNE | Currently Recruiting

  • 1300 343 113

  • 4 nights

  • 5 clinic visits

  • 1300 343 113

This study is looking at an investigational oral drug for people living with obesity or overweight. 

Obesity is a chronic disease that is estimated to affect ~880 million adults globally.  Adults living with obesity and overweight are at higher risk for other health problems. For some people, medicines are recommended to support weight management; however, more treatment options are needed to treat this chronic disease.  The investigational drug is an oral tablet that is designed to help people feel full sooner and reduce feelings of hunger, which may help people eat less over time. 

Requirements

  • Male, Female, Female (Post-menopausal) or Female of non-childbearing potential
  • Healthy
  • 18 - 60 years old
  • BMI 25 - 35 kg/m2
  • Not taking any medications
  • Non-smoker or Occasional smoker

Start dates

16 Sep 2026

Study visits

4 nights, 5 clinic visits

Remuneration

Up to $4,200
Learn more about the Indigo StudyApply

The Food Effect Study

MSP | Currently Recruiting

  • 612-315-6490

  • 3 nights

  • 2 clinic visits

  • 612-315-6490

At Nucleus Network, we lead the way in advancing medical research through clinical trials that explore new investigational medicines aimed at improving lives across a wide range of health conditions.

We’re currently inviting healthy volunteers to take part in a clinical study for add on treatment to major depressive disorder.

Recruiting soon Part B: Food Effect group

Requirements

  • Male or Female
  • Healthy
  • 18 - 55 years old
  • BMI 18 - 30 kg/m2

Study visits

3 nights, 2 clinic visits

Remuneration

$3,886
Learn more about the Food Effect StudyApply

25-008 - Healthy Volunteer Study

LON | Currently Recruiting

  • 0800 783 8792

  • 2 - 4 nights

  • at least 2 clinical visits

  • 0800 783 8792

A study investigating an experimental new medicine for problems with thinking such as memory and concentration, linked to brain disorders like Alzheimer’s disease (AD) and schizophrenia.

Requirements

  • Male or Female
  • Healthy
  • 18 - 55 years old
  • BMI 18 - 30.9 kg/m2

Start dates

3 Sep 2026

Study visits

2 - 4 nights, at least 2 clinical visits

Study payment

£1,250 - £2,315
Learn more about 25-008 - Healthy Volunteer StudyApply

24-503 – People with CIPN

LON | Currently Recruiting

  • 0800 783 8792

  • 6 clinic visits

  • 0800 783 8792

People with Chemotherapy Induced Peripheral Neuropathy (CIPN) needed for the study of a potential new medicine, given as a gel, to treat the condition. You must be aged 18 to 80, have received chemotherapy treatment for cancer and be in remission, and have had CIPN for at least 3 months. It involves up to 6 outpatient visits (including 3 optional skin biopsies) and 1 telephone follow-up. Study ongoing.

Requirements

  • Male or Female
  • Patient
  • 18 - 80 years old

Study visits

6 clinic visits

Study payment

Up to £2,380
Learn more about 24-503 – People with CIPNApply

The Kidney Dynamics Study

MEL | Currently Recruiting

  • 1300512434

  • 6 nights

  • 2 clinic visits

  • 1300512434

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney failure. It is a genetic condition which causes cysts to develop in the kidneys and can eventually lead to kidney failure.  

Currently, there is only one approved treatment for ADPKD. While this treatment can be effective at slowing the disease down, it can cause serious side effects relating to the liver. 

The study drug, RT‑312 has been designed to avoid these harmful side effects in the liver, providing a potentially safer medication to those living with ADPKD. 

Requirements

  • Male, Female or Female of non-childbearing potential
  • Healthy
  • 18 - 45 years old
  • BMI 18 - 32 kg/m2
  • Not taking any medications
  • Non-smoker or Occasional smoker

Start dates

8 Sep 2026

Study visits

6 nights, 2 clinic visits

Remuneration

$4,100 - $4,350
Learn more about the Kidney Dynamics StudyApply

The Kidney Dynamics Study

MEL | Currently Recruiting

  • 1300 512 434

  • 3 nights

  • 1 clinic visit

  • 1300 512 434

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney failure. It is a genetic condition which causes cysts to develop in the kidneys and can eventually lead to kidney failure.  

Currently, there is only one approved treatment for ADPKD. While this treatment can be effective at slowing the disease down, it can cause serious side effects relating to the liver. 

The study drug, RT‑312 has been designed to avoid these harmful side effects in the liver, providing a potentially safer medication to those living with ADPKD. 

Requirements

  • Male or Female
  • Healthy
  • 18 - 45 years old
  • BMI 18 - 32 kg/m2
  • Not taking any medications
  • Non-smoker or Occasional smoker

Start dates

10 Sep 2026

Study visits

3 nights, 1 clinic visit

Remuneration

Up to $2,300
Learn more about the Kidney Dynamics StudyApply

25-011 – Healthy participants

LON | Currently Recruiting

  • 0800 783 8792

  • From 3 nights

  • 5 clinic visits

  • 0800 783 8792

Healthy participants needed for the study of an experimental new treatment for primary biliary cholangitis (PBC). You must be aged 18 to 65 and have a BMI between 18 and 30. Smokers and vapers are allowed but you can’t smoke or vape while in the ward. It involves 3 nights’ residence on our wards and 5 outpatient visits (if on placebo), plus 1 additional follow-up (if you receive the study drug). Admissions on 5 and 6 October 2026.

Requirements

  • Male or Female
  • Healthy
  • 18 - 65 years old
  • BMI 18 - 30 kg/m2

Start dates

5 Oct 2026

Study visits

From 3 nights, 5 clinic visits

Study payment

£3,000 - £4,000
Learn more about 25-011 – Healthy participantsApply

3 steps to get started

Step 1

Register your interest

Explore our current trials and complete a short eligibility form. This helps us understand if you meet the basic criteria for one of our upcoming studies.

Step 2

Speak with our team

You can either call us directly or schedule a time that works for you. We’ll arrange a conversation with our recruitment team to confirm your eligibility, answer any questions, and match you with a suitable study.

Step 3

Screening appointment

Visit the clinic for a free health check. You’ll meet with a medical officer to review your medical history, complete a physical exam, and go through the informed consent process. If you pass screening and eligibility, you’ll be booked into the trial.

Check your eligibility